Fig. 5

IC50 of the sorafenib individually and combined with LINC00162 siRNA transfection. siRNA-mediated silencing of the LINC00162 sensitized B-CPAP cells to sorafenib and reduced the IC50 value from 11.48 µg/ml to 7.760 µg/ml.

IC50 of the sorafenib individually and combined with LINC00162 siRNA transfection. siRNA-mediated silencing of the LINC00162 sensitized B-CPAP cells to sorafenib and reduced the IC50 value from 11.48 µg/ml to 7.760 µg/ml.